WuXi NextCode, the parent company of Genomics Medicine Ireland, has split from its Chinese operations in a major corporate restructuring.
The company said it had to overhaul its structure after China introduced new national security regulations which make it harder for foreign genetic research companies to share data.
In the newly restructured companies, the Chinese operations in Shanghai will retain the WuXi NextCode name while the American, Icelandic and Irish operations will merge under a...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team